Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clonal Hematopoiesis”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Not applicableLooking for participantsNCT02604563
What this trial is testing

Aging, Geriatric Syndromes and Clonal Hematopoiesis

Who this might be right for
GeriatricsAgedGeriatric Syndromes+1 more
Washington University School of Medicine 2,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07435636
What this trial is testing

Modulation of Stem Cell Differentiation in Individuals With High Risk Clonal Haematopoiesis

Who this might be right for
Clonal Cytopenia of Uncertain SignificanceCCUS Clonal Cytopenia of Undetermined SignificanceClonal Hematopoiesis
Clinical Hub for Interventional Research (CHOIR) 80
Not applicableStudy completedNCT04581057
What this trial is testing

Correlation Between Clonal Hematopoiesis, Cardio-vascular Events, Inflammation and Atherosclerosis

Who this might be right for
Myocardial Infarction
University Hospital, Bordeaux 114
Not applicableLooking for participantsNCT05711173
What this trial is testing

Clonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE)

Who this might be right for
Venous ThrombosesThromboembolic DiseaseNeutrophil Extracellular Trap Formation+1 more
University Hospital, Bordeaux 150
Not applicableLooking for participantsNCT06701214
What this trial is testing

The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository

Who this might be right for
Clonal Hematopoiesis
Vanderbilt-Ingram Cancer Center 800
Not applicableStudy completedNCT05146414
What this trial is testing

Clonal Hematopoiesis of Indeterminate Potential and Accelerated Atherosclerosis in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Assistance Publique - Hôpitaux de Paris 500
Not applicableLooking for participantsNCT04541654
What this trial is testing

Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress

Who this might be right for
Li-Fraumeni SyndromeTP53 Gene MutationHereditary Cancer Syndrome+2 more
Dana-Farber Cancer Institute 1,500
Post-approval studies (Phase 4)Not Yet RecruitingNCT07362966
What this trial is testing

Effect of Colchicine on Progression of Coronary Atherosclerosis in Patients With TET2-CHIP Variant

Who this might be right for
ColchicineCoronary Atherosclerosis ManagementClonal Hematopoiesis of Indeterminate Potential
Shenyang Northern Hospital 120
Not applicableUnknownNCT05828888
What this trial is testing

CHIP in Endothelial Dysfunction Associated With HEpEF

Who this might be right for
Heart Failure With Preserved Ejection Fraction
University Hospital, Bordeaux 80
Not applicableLooking for participantsNCT05705531
What this trial is testing

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Who this might be right for
Cardiovascular DisorderClassic Hodgkin LymphomaClonal Hematopoiesis
Children's Oncology Group 190
Not applicableStudy completedNCT05981144
What this trial is testing

Exploration of Clonal Hematopoiesis of Indeterminate Potential in Non-ischemic Heart Failure With Reduced Ejection Fraction

Who this might be right for
Heart Failure With Reduced Ejection Fraction
Yonsei University 100
Not applicableLooking for participantsNCT05246813
What this trial is testing

Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)

Who this might be right for
OsteoporosisOsteoarthritis, HipHip Fractures+2 more
Imelda Hospital, Bonheiden 24
Not applicableStudy completedNCT04987268
What this trial is testing

CHIP and Residual Cardiovascular Event Tendency After Smoking Cessation

Who this might be right for
ACSClonal Hematopoiesis of Indeterminate PotentialSmoking Cessation
Shenyang Northern Hospital 1,029
Not applicableLooking for participantsNCT06295965
What this trial is testing

Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma+7 more
University of Washington 2,000
Early research (Phase 1)Not Yet RecruitingNCT07249840
What this trial is testing

Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis

Who this might be right for
JAK2 Mutation
Brigham and Women's Hospital 12
Testing effectiveness (Phase 2)Looking for participantsNCT06303193
What this trial is testing

Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms

Who this might be right for
Myelodysplastic Syndromes
National Cancer Institute (NCI) 160
Not applicableLooking for participantsNCT06626685
What this trial is testing

Clonal Hematopoiesis of Indeterminate Potential in Heart Failure.

Who this might be right for
Heart Failure
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS 300
Testing effectiveness (Phase 2)Study completedNCT06097663
What this trial is testing

Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)

Who this might be right for
Coronary Heart DiseaseClonal Hematopoiesis of Indeterminate Potential (CHIP)
Novartis Pharmaceuticals 31
Not applicableUnknownNCT04174547
What this trial is testing

An European Platform for Translational Research in Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndromes
Istituto Clinico Humanitas 8,670
Not applicableLooking for participantsNCT06785077
What this trial is testing

Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors

Who this might be right for
Leukemia, Myeloid, AcuteMyeloid DysplasiaOvarian Epithelial Cancer
European Institute of Oncology 157
Load More Results